Hereditary cancer syndromes constitute approximately 10% of all cancers. Cascade testing
involves testing of at-risk relatives to determine if they carry the familial pathogenic variant …

Objective: The objective of this review was to map the available global evidence on
strategies that nurses can use to facilitate genomics-informed health care to address health …

Although multiple factors can influence the uptake of cascade genetic testing, the impact of
proband indication has not been studied. We performed a retrospective, cross-sectional …

Low uptake of genetic services among members of families with hereditary breast and
ovarian cancer (HBOC) suggests limitations of proband-mediated communication of genetic …

Objectives There is limited evidence on health promotion interventions in people with
hereditary cancer syndromes or on their main sources of support and information. This study …

Completion of genetic testing is increasingly important for the complex care of patients with
suspected hereditary breast and ovarian cancers (HBOC) and their at-risk family members …

Introduction Genetic testing for hereditary cancer syndromes (HCSs) can improve health
outcomes through cancer risk mitigation strategies. Effective communication between tested …

Objective Despite the benefits, the rate of genetic testing among first‐degree relatives
(FDRs; parents, children, and siblings) remains low, and the barriers to undergoing testing …

Background Individuals affected with cancer predisposition (CPS) syndromes such as
BRCA1, BRCA2 or Lynch syndrome (LS) are at an elevated risk of multiple cancers …

Genomic testing expansion is accompanied by an increasing need for genetic counselling
and intrafamilial communication. Genetic counselling can play an important role in …